| ²é¿´: 1931 | »Ø¸´: 2 | |||
| ±¾Ìû²úÉú 1 ¸ö LS-EPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
strivingÒø³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇóÖúCSCDÊÕÔØµÄÎÄÕÂһƪÎÄÕ¼ìË÷ºÅ
|
||
|
ÌâÄ¿£º»¯Ñ§ºÏ³ÉÔÁÏÒ©ÆðʼÎïÁϹúÄÚÍâÏà¹ØÒªÇóµÄ±È½Ï ÆÚ¿¯£ºÖйúÐÂÒ©ÔÓÖ¾ |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸»¦9£¬326ÇóÉúÎïѧµ÷¼Á
ÒѾÓÐ7È˻ظ´
»¯¹¤Ñ§Ë¶294·Ö£¬Çóµ¼Ê¦ÊÕÁô
ÒѾÓÐ24È˻ظ´
085600²ÄÁÏÓ뻯¹¤329·ÖÇóµ÷¼Á
ÒѾÓÐ10È˻ظ´
284Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
¸´ÊÔµ÷¼Á
ÒѾÓÐ18È˻ظ´
310Çóµ÷¼Á
ÒѾÓÐ16È˻ظ´
274Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
245Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Óб¬ÁÏ£¬Ò»¸öÇàÄê½ÌʦÂô·¿µÃ400Íò£¬È»ºó»»ÁËÒ»¸öËÄÇàñ×Ó
ÒѾÓÐ11È˻ظ´
290Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
sunshan4379
°æÖ÷ (ÎÄ̳¾«Ó¢)
- LS-EPI: 131
- Ó¦Öú: 218 (´óѧÉú)
- ¹ó±ö: 7.08
- ½ð±Ò: 129140
- É¢½ð: 57852
- ºì»¨: 419
- ɳ·¢: 1036
- Ìû×Ó: 17124
- ÔÚÏß: 4575.2Сʱ
- ³æºÅ: 2420830
- ×¢²á: 2013-04-16
- ÐÔ±ð: GG
- רҵ: Â߼ѧ
- ¹ÜϽ: ¼ìË÷֪ʶ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
striving: ½ð±Ò+5 2014-10-20 15:08:46
oven1986: LS-EPI+1, ¸ÐлӦÖú£¡ 2014-10-20 15:09:34
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
striving: ½ð±Ò+5 2014-10-20 15:08:46
oven1986: LS-EPI+1, ¸ÐлӦÖú£¡ 2014-10-20 15:09:34
|
Comparison of domestic and foreign related requirements of starting materials for synthetic drug substances »¯Ñ§ºÏ³ÉÔÁÏÒ©ÆðʼÎïÁϹúÄÚÍâÏà¹ØÒªÇóµÄ±È½Ï ×÷Õß:Wang Hongliang; Chen Zhen ×÷Õß:ÍõºêÁÁ; ³ÂÕð Chinese Journal New Drugs ÖйúÐÂÒ©ÔÓÖ¾ ¾í:23 ÆÚ:9 Ò³:998-1003 ÎÄÏ׺Å:1003-3734(2014)23:9<998:HXHCYL>2.0.TX;2-V ³ö°æÄê:2014 ÕªÒª The selection and quality control of starting materials are an important part of drug substance development. In the past 20 years, this topic involves in the technical requirements for drug substance registration, and gets attention quite all time. As the publication of ICH Q11 guideline, agreement on general selection principles and quality control requirements of starting materials has been reached in ICH regions. In comparison, we are still lagging behind in the understanding of this topic. In this article, we reviewed FDA, EMA, ICH and domestic related requirements of starting materials for synthetic drug substances. Furthermore, we analyzed our existing problems focusing on the regulatory function, selection principles, and document submission requirements for starting materials. We want to provide a reference to amend the domestic related requirements for starting materials. ÕªÒª:ÆðʼÎïÁϵÄÑ¡Ôñ¼°ÖÊÁ¿¿ØÖÆÊÇÔÁÏÒ©¿ª·¢µÄÖØÒª×é³É²¿·Ö¡£½ü20ÄêÀ´,ÔÚÔÁÏÒ©×¢²á¼¼ÊõÒªÇóÖÐ,ÕâÒ»»°ÌâÒ»Ö±¹ãÊܹØ×¢¡£Ëæ×ÅICH Q11Ö¸µ¼ÔÔòµÄ³ǫ̈,ICHµØÇø¶ÔÆðʼÎïÁÏÑ¡ÔñµÄ»ù±¾ÔÔò¼°ÖÊÁ¿¿ØÖÆÒªÇó´ï³É¹²Ê¶¡£Ïà±È½Ï¶øÑÔ,ÎÒ¹ú¶Ô´ËÎÊÌâµÄÈÏʶÉÐÏÔÖͺ󡣱¾ÎĶÔÃÀ¹ú¡¢Å·ÃË¡¢ICHÒÔ¼°¹úÄÚ¹ØÓÚ»¯Ñ§ºÏ³ÉÔÁÏÒ©ÆðʼÎïÁϵÄÏà¹ØÒªÇó½øÐÐÁË×ÛÊö,²¢¶ÔÎÒ¹úÔÚÆðʼÎïÁϵļà¹Ü×÷Óá¢Ñ¡ÔñÔÔò¡¢×ÊÁÏÌá½»ÒªÇóµÈ·½Ãæ´æÔÚµÄÎÊÌâ½øÐÐÁË·ÖÎö,Ϊ½øÒ»²½ÍêÉÆÎÒ¹úµÄÏà¹ØÒªÇóÌṩ²Î¿¼¡£ ¹Ø¼ü´Ê ×÷Õ߹ؼü´Ê:drug substance; starting material; guideline; technical requirements ×÷Õ߹ؼü´Ê:ÔÁÏÒ©; ÆðʼÎïÁÏ; Ö¸µ¼ÔÔò; ¼¼ÊõÒªÇó ×÷ÕßÐÅÏ¢ µØÖ·: Wang Hongliang, National Engineering Research Center for Strategic Drugs, Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing 100850, China. Chen Zhen, Center for Drug Evaluation,China Food and Drug Administration, Beijing 100038, China. µØÖ·: ÍõºêÁÁ, ¾üÊÂҽѧ¿ÆÑ§Ôº¶¾ÎïÒ©ÎïÑо¿Ëù, ¹ú¼ÒÓ¦¼±·À¿ØÒ©Î﹤³Ì¼¼ÊõÑо¿ÖÐÐÄ, ±±¾© 100850, Öйú. ³ÂÕð, ¹ú¼ÒʳƷҩƷ¼à¶½¹ÜÀí×ܾÖÒ©Æ·ÉóÆÀÖÐÐÄ, ±±¾© 100038, Öйú. µç×ÓÓʼþµØÖ·:whl.pharmacy@gmail.com, chenzh@cde.org.cn µç×ÓÓʼþµØÖ·:whl.pharmacy@gmail.com, chenzh@cde.org.cn Àà±ð / ·ÖÀà Ñо¿·½Ïò harmacology & Pharmacy (ÓÉ Thomson Reuters Ìṩ)ÎÄÏ×ÐÅÏ¢ ÎÄÏ×ÀàÐÍ:Article ÓïÖÖ:Chinese Èë²ØºÅ:CSCD:5139351 ISSN:1003-3734 ÆäËûÐÅÏ¢ Öйú¿ÆÑ§ÒýÎÄÊý¾Ý¿âÖÐµÄ "ÒýÓõIJο¼ÎÄÏ×": 18 ÔÚÖйú¿ÆÑ§ÒýÎÄÊý¾Ý¿âÖеı»ÒýƵ´Î: 0 |

2Â¥2014-10-20 15:05:08
sunshan4379
°æÖ÷ (ÎÄ̳¾«Ó¢)
- LS-EPI: 131
- Ó¦Öú: 218 (´óѧÉú)
- ¹ó±ö: 7.08
- ½ð±Ò: 129140
- É¢½ð: 57852
- ºì»¨: 419
- ɳ·¢: 1036
- Ìû×Ó: 17124
- ÔÚÏß: 4575.2Сʱ
- ³æºÅ: 2420830
- ×¢²á: 2013-04-16
- ÐÔ±ð: GG
- רҵ: Â߼ѧ
- ¹ÜϽ: ¼ìË÷֪ʶ

3Â¥2014-10-20 15:08:48














»Ø¸´´ËÂ¥
harmacology & Pharmacy (ÓÉ Thomson Reuters Ìṩ)
10